James T. Parsons, Chief Financial Officer at Trillium Therapeutics Inc. (TRIL), sold 17,010 shares at $15.79 ($269K) on 2021-01-08, disclosed to the SEC on 2021-01-12.
Open-market sale of $269k TRIL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.79 | 8,505 | $134K | 50.0% |
| 2 | $15.79 | 8,505 | $134K | 50.0% |
| Total | $15.79 avg | 17,010 | $269K | 100% |
| Filing → |